Drug-resistant ventilator associated pneumonia in a tertiary care hospital in Saudi Arabia

Annals of Thoracic Medicine

Volumn 9, Issue 2, 2014, Pages 104-111

  Balkhy, Hanan H ^a,b,c   El Saed, Aiman ^a,b,c,d   Maghraby, Rana ^a   Al Dorzi, Hasan M ^a,c   Khan, Raymond ^a   Rishu, Asgar H ^a   Arabi, Yaseen M ^a,c  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b WHO Collaborating Center for Infection Prevention and Control   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acinetobacter; antimicrobial resistance; microbiology; Saudi Arabia; ventilator associated pneumonia

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; OXACILLIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ACINETOBACTER; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SAUDI ARABIA; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTER; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84898745087     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.128858     Document Type: Article

References (26)

1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000;21:510-5.
2. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010;38:95-1042.
3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
4. Amin A. Clinical and economic consequences of ventilatorassociated pneumonia. Clin Infect Dis 2009;49 Suppl 1:S36-43.
5. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
6. Arabi Y, Al-Shirawi N, Memish Z, Anzueto A. Ventilatorassociated pneumonia in adults in developing countries: A systematic review. Int J Infect Dis 2008;12:505-12.
7. Akova M. Emerging problem pathogens: A review of resistance patterns over time. Int J Infect Dis 2006;10:3-8.
8. Al Johani SM, Akhter J, Balkhy H, El-Saed A, Younan M, Memish Z. Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Ann Saudi Med 2010;30:364-9.
9. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011.
10. Kallen AJ, Hidron AI, Patel J, Srinivasan A. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010;31:528-31.
11. Asghar AH, Faidah HS. Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia. Saudi Med J 2009;30:1017-23.
12. Saeed NK, Kambal AM, El-Khizzi NA. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med J 2010;31:1341-9.
13. Al-Dorzi HM, El-Saed A, Rishu AH, Balkhy HH, Memish ZA, Arabi YM. The results of a 6-year epidemiologic surveillance for ventilator-associated pneumonia at a tertiary care intensive care unit in Saudi Arabia. Am J Infect Control 2012;40:794-9.
14. CDC. NNIS Criteria for Determining Nosocomial Pneumonia. Atlanta, GA: US Department of Health and Human Services, CDC; 2003.
15. th ed. Approved standard. M2-A8. Wayne, PA: Clinical and Laboratory Standards Institute; 2003.
16. Lagamayo EN. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries. Am J Infect Control 2008;36:S101-8.
17. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin Microbiol Infect 2006;12:826-36.
18. Rello J, Díaz E, Rodríguez A. Etiology of ventilator-associated pneumonia. Clin Chest Med 2005;26:87-95.
19. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005;11:868-73.
20. Balkhy H, El-Saed A, Jabri F. Antimicrobial consumption in four different adult intensive care units in a Saudi tertiary care hospital. Int J Infect Dis Control 2011;7:P5.
21. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-21.
22. El-Saed A, Balkhy HH, Al-Dorzi HM, Khan R, Rishu AH, Arabi YM. Acinetobacter is the most common pathogen associated with lateonset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. Int J Infect Dis 2013;17:e696-701.
23. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006;145:582-91.
24. Meyer E, Schwab F, Gastmeier P. Nosocomial methicillin resistant staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009). Eur J Med Res 2010;15:514-24.
25. Combes A, Luyt CE, Trouillet JL. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia. Semin Respir Crit Care Med 2006;27:23-8.
26. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003;36:1433-7.